📰 Presents News
Page 242 - Presents News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Presents. Real-time updates on events, politics, business and more.
April 29, 2021
Liquid Avatar Technologies Inc.: Liquid Avatar Presents Digital Wallets & Verifiable Credentials - The Future of Online Identity Live Online Webinar May 18th TORONTO, ON / ACCESSWIRE / CSE:LQID)( FRA:4T51) ("Liquid Avatar Technologies" or the " Company"), a global blockchain, digital identity and fintech solutions company is presenting a major online event to provide an easy to understand and digestible overview of digital identity, wallets and verifiable credentials and how they are changing ...
April 18, 2021
The Monday Q&A: Wen Xiong from Wens Story Den 18 Apr, 2021 05:00 PM 4 minutes to read Wen Xiong will be part of the upcoming Mythical, Mysterious and Magical Creatures Night at the Whanganui Regional Museum. Photo / Bevan Conley Wen Xiong will be part of the upcoming Mythical, Mysterious and Magical Creatures Night at the Whanganui Regional Museum. Photo / Bevan Conley Mike Tweed is a multimedia journalist at the Whanganui Chroniclemichael.tweed@nzme.co.nzWhangaChron Wen Xiong is a Whanganui ea...
April 17, 2021
Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers Elucid Software Quantifies Plaque Morphology to Enable Better Assessment of IPE Treatment Effects Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced that first author and Elucid founder Andrew Buckler presented findings today from the EVAPORATE (Effect of Vascepa on Improving Coronary ...
April 14, 2021
The climate crisis is ostensibly a big polluter problem. But does population size matter?
April 13, 2021
Hopium presents UNA, its California-based subsidiary dedicated to blockchain technology The French car manufacturer Hopium continues to imagine the future of mobility by integrating blockchain technology at the source of the development of its hydrogen vehicle, a first in the automotive industry. Through UNA, its Californian subsidiary based in Silicon Beach, Hopium intends to harness emerging technologies to service both mankind and nature. The manufacturer aims to contribute to the decarboniz...
April 13, 2021
- Preclinical study evaluated melanocortin 1 receptor (MC1R) as a potential target for MC1R-targeted therapies for metastatic melanoma, the lead target of VMT01 - - Results indicate that MC1R-targeted
April 13, 2021
13 aprile 2021 17:02 Fonte: Adnkronos #auto-e-motori PARIS, April 13, 2021 /PRNewswire/ -- The French car manufacturer Hopium continues to imagine the future of mobility by integrating blockchain technology at the source of the development of its hydrogen vehicle, a first in the automotive industry. Through UNA, its Californian subsidiary based in Silicon Beach, Hopium intends to harness emerging technologies to service both mankind and nature. The manufacturer aims to contribute to...
April 13, 2021
Covering Climate Now: How can we move greener? 13 Apr, 2021 05:00 PM 6 minutes to read NZ Herald aviation writer Grant Bradley reveals whats ahead for the aviation industry to become more efficient and how aircraft can shift away from fossil fuels. Video / NZ Herald / Supplied NZ Herald aviation writer Grant Bradley reveals whats ahead for the aviation industry to become more efficient and how aircraft can shift away from fossil fuels. Video / NZ Herald / Supplied Climate change presents an exi...
April 12, 2021
If all of us moved to climate-friendly diets, what difference would it make to emissions?
April 12, 2021
(2) PRESS RELEASE Immunocore presents phase 3 data comparing tebentafusp with investigators choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting Tebentafusp is the first investigational therapy to improve Overall Survival (OS) in patients with metastatic uveal melanoma First positive Phase 3 clinical trial for any T cell receptor therapeutic and first for any bispecific in a solid tumor (Nasdaq: IMCR), a late-stage biotechnology com...